Coronavirus Update: US To Begin Mass Vaccinations After Pfizer’s Historic Emergency Authorization

Plus: India To Examine Healthcare Access

The first vaccinations are due to begin in the US, with the government extending its agreement with Moderna to bolster its vaccines supplies.

Pfizer Trucks
The first consignments of the vaccines left Pfizer's manufacturing facility near Kalamazoo, Michigan on 13 December. • Source: Pfizer

The first immunizations against COVID-19 in the United States are to begin on 14 December, following the historic first emergency use authorization (EUA) of a vaccine, Pfizer/BioNTech’s BNT162b2.

The messenger RNA vaccine was granted the emergency clearance by the US Food and Drug Administration late on 11 December,...

More from COVID-19

More from Scrip

Stock Watch: Q2 Sales Growth Sparks Diverging Reactions To J&J And Novartis

 
• By 

With drug sector indexes underperforming the broad market in the first half of 2025, investors may have been anticipating tariff-related and other headwinds. But impending loss of exclusivity on key products may be provoking more anxiety at this point.

Sanofi Doubles Down On Respiratory Vaccines With Vicebio Buy

 
• By 

The French major is paying $1.15bn For the UK biotech and its bivalent candidate, VXB-241.

Chinese Biotechs Sweep ADC Plus PD-(L)1/VEGF Bispecific Combos Into Phase II

 

Chinese firms Junshi, Minghui and RemeGen rank among the world’s few players progressing antibody-drug conjugates combined with PD-(L)1/VEGF bispecific antibodies in Phase II trials for various cancers.